Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

OrbiMed

Tracked across 5 events · 50 articles · First seen Mar 17, 2026 · Last active Aug 19, 2026

Sentiment
44
Attention
6
Events
5
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 60
Business
Impact: OrbiMed led a $32 million funding round for Pee Safe, becoming a key investor and facilitating the exit of early-stage investors.
Mar 17, 2026 · 6 articles
2 60
Business
Impact: OrbiMed invested in Iswarya, extending its India portfolio into fertility care, reflecting confidence in the sector's growth.
Jul 09, 2026 · 7 articles
4 50
Business
Fulcrum Therapeutics and Slate Medicines have signed a definitive all-stock merger agreement to create a combined company focused on next-generation migraine treatments. The combined entity will operate as Slate Medicines and trade on Nasdaq under…
Impact: OrbiMed participated in the private placement financing.
Aug 17, 2026 · 6 articles
6 40
Business
Impact: Healthcare investment firm; suggests Novo needs deals to compete long-term.
Aug 03, 2026 · 6 articles
4 10
Business
Impact: OrbiMed is a venture backer of Scribe. The IPO provides a return on their investment.
Jul 06, 2026 · 25 articles
ERGEN INTELLIGENCE
Track OrbiMed live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.